GMO analyzed 700+ LBOs and found they skewed massively toward small, lower-quality, highly leveraged companies. Only one mega-cap LBO has ever occurred in US history. The average endowment with 50% in private equity is unknowingly running a giant concentrated bet on small-cap junk.